We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$22.1B
AUM Growth
+$302M
(+1.4%)
Cap. Flow
-$1.16B
Cap. Flow
% of AUM
-5.26%
Top 10 Holdings %
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$148M |
| 2 |
Netflix
NFLX
|
+$119M |
| 3 |
Airbnb
ABNB
|
+$111M |
| 4 |
XYZ
Block Inc
XYZ
|
+$89.5M |
| 5 |
Danaher
DHR
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$212M |
| 2 |
Alibaba
BABA
|
+$172M |
| 3 |
Zoetis
ZTS
|
+$133M |
| 4 |
TransUnion
TRU
|
+$124M |
| 5 |
Baidu
BIDU
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.01% |
| 2 | Miscellaneous | 17.67% |
| 3 | Financials | 13.76% |
| 4 | Consumer Discretionary | 12.07% |
| 5 | Technology | 11.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Crocs
CROX
$5.48B
| $35.4M | 0.16% |
303,874
+285,854
| +1,586% | +$28.1M |
|
127
RH
RH
$2.7B
| $35.1M | 0.16% |
51,631
-45,026
| -47% | -$29.2M |
|
128
Bio-Techne
TECH
$11.3B
| $35M | 0.16% |
311,092
-702,324
| -69% | -$73.9M |
|
129
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4.19B
| $34.4M | 0.16% |
+356,000
| New | +$31.1M |
|
130
PUT
Meta Platforms (Facebook)
META
$1.56T
| $34.4M | 0.16% |
98,900
+91,400
| +1,219% | +$29.3M |
|
131
Ralph Lauren
RL
$20.7B
| $34.3M | 0.16% |
291,430
+207,686
| +248% | +$26M |
|
132
Akamai
AKAM
$15.2B
| $34.1M | 0.15% |
292,397
+276,775
| +1,772% | +$30.9M |
|
133
Snap
SNAP
$9.18B
| $33.8M | 0.15% |
495,643
-95,540
| -16% | -$5.73M |
|
134
Travelers Companies
TRV
$76.3B
| $33.5M | 0.15% |
224,006
+80,600
| +56% | +$12.5M |
|
135
Berkshire Hathaway Class B
BRK.B
$1.08T
| $33.4M | 0.15% |
120,208
-73,577
| -38% | -$20.6M |
|
136
Canadian Pacific Kansas City
CP
$80.1B
| $33.2M | 0.15% |
431,305
+403,305
| +1,440% | +$31.3M |
|
137
Stellantis
STLA
$15.6B
| $33.1M | 0.15% |
1,687,112
-23,335
| -1% | -$439K |
|
|
DNMR
138
DELISTED
Danimer Scientific, Inc.
DNMR
| $33M | 0.15% |
32,897
+25,645
| +354% | +$25.6M |
|
139
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$47.1B
| $32.8M | 0.15% |
+226,900
| New | +$31.7M |
|
140
Personalis
PSNL
$1.77B
| $32.7M | 0.15% |
1,294,227
+743,691
| +135% | +$17M |
|
141
Royal Bank of Canada
RY
$289B
| $32.5M | 0.15% |
320,476
+63,679
| +25% | +$6.31M |
|
142
PUT
iShares MSCI Emerging Markets ETF
EEM
$32B
| $32.2M | 0.15% |
583,700
+497,600
| +578% | +$27M |
|
143
Huazhu Hotels Group
HTHT
$13.6B
| $32M | 0.14% |
606,177
-233,015
| -28% | -$13.1M |
|
|
EXE
144
Expand Energy Corp
EXE
$22.7B
| $32M | 0.14% |
616,321
-258,326
| -30% | -$12.9M |
|
145
Southern Company
SO
$102B
| $31.8M | 0.14% |
526,237
+398,866
| +313% | +$25.5M |
|
146
Abbott
ABT
$183B
| $31.8M | 0.14% |
274,648
+112,673
| +70% | +$13.1M |
|
147
Goldman Sachs
GS
$302B
| $31.7M | 0.14% |
83,580
+76,790
| +1,131% | +$27.5M |
|
148
PUT
iShares Semiconductor ETF
SOXX
$43.5B
| $31.7M | 0.14% |
+209,100
| New | +$29.9M |
|
149
McDonald's
MCD
$181B
| $31.5M | 0.14% |
136,504
+4,921
| +4% | +$1.15M |
|
150
S&P Global
SPGI
$127B
| $31M | 0.14% |
75,423
-40,139
| -35% | -$15.4M |
|
Similar funds
Marshall Wace's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Marshall Wace withdrew a net $1.16B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.
- Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
- Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
- Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
- Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
- Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
- Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
- Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.
Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.